The Legacy Demineralized Bone Matrix (DBM) is a putty for filling voids or gaps in boney defects. Credit: Orthofix Medical Inc./ Business Wire.

Orthofix Medical has announced the complete commercial release and first patient implant of its Legacy Demineralized Bone Matrix (DBM).

The Legacy DBM is a putty which has been developed to fill voids or gaps in boney defects or traumatic injuries of the spine, pelvis, or extremities.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It has a putty-like consistency and can be used as an extender with allograft or autograft, or with bone marrow aspirate.

Non-profit organisation MTF Biologics has processed the Legacy DBM using its specialised processing techniques that maintain the inherent growth factors present in bone.

University Orthopedics Spine Surgery chief Dr Alan Daniels has implanted the Legacy DBM in the first patient.

See Also:

Dr Daniels said: “Bone healing is a dynamic process where multiple factors play an integral role in deciding which biologic best meets the individual needs of the patient to aid them on their road to recovery.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Legacy DBM provides a cost-effective option, without compromising clinical experience or the handling needed in a bone matrix.”

Orthofix Medical noted that Legacy DBM joins its recently introduced FiberFuse Advanced and FiberFuse Strip allografts, Trinity Elite, Virtuos Lyograft, and the AlloQuent structural allograft portfolio.

The company also sells and distributes the OpusMg Set bone void filler, the O-Genesis graft delivery system, Opus One osteoconductive scaffold, and Opus BA bioactive bone graft.

Orthofix Global Spine president Kevin Kenny said: “The Legacy DBM is another example of our continued commitment to expanding biologic offerings to meet the needs of surgeons and their patients.

“In the past year alone, we have introduced five new biologics, including the Virtuos Lyograft, a first-of-its-kind, shelf-stable, and complete autograft substitute.

“We understand there are unique surgeon users for a wide range of bone-grafting options, and it is our goal to be a leading provider of these biologic offerings to our customers.”